In Part I of FierceBiotech Radio's BIO 2015 special, Editor-in-Chief John Carroll moderates a discussion on cancer R&D, featuring leaders from AstraZeneca, Juno Therapeutics, Merck, Johnson & Johnson and GlaxoSmithKline. Visit FierceBiotech.com for video of the event.